IDO1 and colitis: Experimental studies further suggest that manipulating this pathway can influence disease severity: IDO1 deficiency attenuates inflammation via downregulation of proinflammatory signaling [10], whereas its overexpression aggravates colitis through macrophage M1 polarization [7].